Okay.
Dr. Langley, drawing on the advice of the vaccine task force last September, the federal government pre-ordered 72 million doses of the vaccine candidate developed jointly by GlaxoSmithKline and Sanofi. It's Canada's second-largest vaccine supply agreement.
I think you currently hold the $700,000 CIHR-GlaxoSmithKline chair in pediatric vaccinology at Dalhousie University. I believe you have worked with Sanofi on research and as a consultant in the past. By standard conflict measures, was it appropriate for you to not recuse yourself from discussions relating to the GSK-Sanofi vaccine candidate?